Insider · CIK 0001726070
Morgan C S Kurk
Files at CMBMF (Cambium Networks Corp). First filing -, latest -.
Morgan C S Kurk files SEC Form 4 as CEO, president and director at CMBMF (Cambium Networks Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Morgan C S Kurk has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | CMBMF Cambium Networks Corp | FTax withholding Ordinary Shares | -1,721 | $0.29 | $499 | 84,248 | May 20, 2026 |
| Feb 18, 2026 | CMBMF Cambium Networks Corp | FTax withholding Ordinary Shares | -2,109 | $1.21 | $2,552 | 85,969 | Feb 20, 2026 |
| Nov 18, 2025 | CMBMF Cambium Networks Corp | FTax withholding Ordinary Shares | -1,788 | $2.61 | $4,667 | 88,078 | Nov 20, 2025 |
| Aug 18, 2025 | CMBMF Cambium Networks Corp | FTax withholding Ordinary Shares | -14,300 | $0.69 | $9,838 | 89,866 | Aug 20, 2025 |
Questions about Morgan C S Kurk
Answered from the filings on this page, as of the latest one.
Is Morgan C S Kurk buying or selling?
Morgan C S Kurk has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Morgan C S Kurk's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Morgan C S Kurk has 0.
Where does Morgan C S Kurk file Form 4?
Morgan C S Kurk has filed Form 4 at CMBMF (Cambium Networks Corp) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.